Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Rating) has been given a consensus rating of “Hold” by the nine ratings firms that are covering the firm, reports Marketbeat.com. One equity research analyst has rated the stock with a sell recommendation, four
Brooklyn News: Locals Rally for Toñita’s
Park Slope HDFC Edwardian Flat With High Ceilings, Three Bedrooms, Storage Asks $500K
Up a short flight of steps on the elevated first floor of a Park Slope HDFC co-op, this modernized Edwardian flat has high ceilings, three bedrooms, and

